دورية أكاديمية
Low-friction arthroplasty with Boneloc bone-cement: outcome at 2 to 4 years.
| العنوان: | Low-friction arthroplasty with Boneloc bone-cement: outcome at 2 to 4 years. |
|---|---|
| المؤلفون: | Walczak JP; Eastbourne District General Hospital Trust, East Sussex, United Kingdom., D'Arcy JC, Ross KR, James SE, Bonnici AV, Koka SR, Morris RW |
| المصدر: | The Journal of arthroplasty [J Arthroplasty] 2000 Feb; Vol. 15 (2), pp. 205-9. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Taylor and Francis Country of Publication: United States NLM ID: 8703515 Publication Model: Print Cited Medium: Print ISSN: 0883-5403 (Print) Linking ISSN: 08835403 NLM ISO Abbreviation: J Arthroplasty Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: New Brunswick, NJ : Taylor and Francis Original Publication: [New York, NY : Churchill Livingstone, c1986- |
| مواضيع طبية MeSH: | Arthroplasty, Replacement, Hip*/methods , Bone Cements* , Methacrylates*, Aged ; Female ; Follow-Up Studies ; Humans ; Male ; Proportional Hazards Models ; Prosthesis Failure ; Reoperation ; Survival Rate ; Time Factors ; Treatment Outcome |
| مستخلص: | We report the clinical and radiologic outcome of 109 Chamley low-friction arthroplasties implanted with Boneloc bone-cement (Biomet, Bridgend, South Wales, UK) into 104 patients. The mean follow-up was 30 months (range, 2-48 months). There were 72 women (mean age, 71 years) and 32 men (mean age, 72). Cartridge-packed cement was used in 37 cases and vacuum-packed cement in 72 cases. Survivorship analysis based on revision for aseptic loosening showed 79% survival at 4 years. Seventeen (15.5%) hips have been revised for aseptic loosening to date, in which all stems and 4 cups were loose. Extensive femoral osteolysis was always present and resulted in 4 cases of femoral cortical perforation at revision. Survivorship analysis based on revision and radiologic failure showed only 55% survival over the same period. When radiologic loosenings were included as failures, the vacuum-packed cement performed significantly worse than the cartridge-packed cement it replaced. These poor results were consistent with the withdrawal of Boneloc from clinical use in 1995, and we recommend indefinite follow-up for surviving prostheses. |
| المشرفين على المادة: | 0 (Bone Cements) 0 (Methacrylates) 138366-79-7 (methylmethacrylate-n-decylmethacrylate-isobornylmethacrylate) |
| تواريخ الأحداث: | Date Created: 20000309 Date Completed: 20000328 Latest Revision: 20190910 |
| رمز التحديث: | 20231215 |
| DOI: | 10.1016/s0883-5403(00)90264-x |
| PMID: | 10708087 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 0883-5403 |
|---|---|
| DOI: | 10.1016/s0883-5403(00)90264-x |